Chairman and CEO Boris Jordan noted that the inclusion follows the company's 2025 entry into the S&P/TSX Composite Index. According to Jordan, these benchmarks expose the firm's shares to a wider array of passive and active institutional funds, aiming to drive liquidity and broaden the overall shareholder base.

The FTSE Canada All Cap Index, managed by FTSE Russell, tracks the performance of large-, mid-, and small-capitalization companies listed in Canada. For Curaleaf, which operates across medical and adult-use markets, this expansion into a second index serves as a strategic milestone in its efforts to attract investors focused on the U.S. cannabis sector.